See inside. Control in real time.
20+deployed systems across operational biomanufacturing environments
8countries with commercial or pilot deployment footprint
<5%batch failure rate in validated deployments
70%reduction in process development cycle timeOperators set empirical inputs and wait for offline samples. The metabolic state of a living cell culture is measured in snapshots every four to six hours, analyzed elsewhere, and returned already historical.
Five to ten percent of the harvest is lost and has to be discarded.
Failure is detected only four to six hours before the entire harvest is lost.
Substantially less development time than the years previously required. Decisive for pharmaceutical work on new bacterial strains.
Four products.One autonomous stack.
A single control layer for pharmaceutical manufacturers, CDMOs, industrial fermentation operators, and research organizations moving from development to validated production.
Biologics, biosimilars, and cell and gene therapy with continuous metabolic visibility into every run.
Novel modalities, AAV, and bispecifics with process signatures that transfer with the process.
Fed-batch optimization and fleet-level intelligence across amino acids, enzymes, and specialty chemicals.
Every run becomes a fully instrumented experiment, removing the offline-assay bottleneck.
We engage with pharmaceutical manufacturers, CDMOs, industrial biomanufacturers, and research institutions where the platform's capabilities are directly relevant to active operational challenges.
Get in touch →Back to top
